Denmark vs East Asia & Pacific (IDA & IBRD countries): Immunization, Hib3
Immunization, Hib3 over time
- Denmark
- East Asia & Pacific (IDA & IBRD countries)
How they compare
Denmark currently reports 96.0% against 40.1% in East Asia & Pacific (IDA & IBRD countries), a difference of 55.9%.
That makes Denmark's figure about 2.4 times East Asia & Pacific (IDA & IBRD countries)'s.
Across all 32 years both countries report, Denmark has been ahead every year.
Denmark ranks 46th and East Asia & Pacific (IDA & IBRD countries) ranks 43rd of 191 countries.
Denmark has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Denmark | East Asia & Pacific (IDA & IBRD countries) | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 90.3% | 0.0% | 90.3% | Denmark |
| 2000s | 92.7% | 1.2% | 91.5% | Denmark |
| 2010s | 94.2% | 23.0% | 71.2% | Denmark |
| 2020s | 96.8% | 36.7% | 60.1% | Denmark |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Denmark or East Asia & Pacific (IDA & IBRD countries)?
- Denmark, at 96.0% against 40.1% in East Asia & Pacific (IDA & IBRD countries) as of 2024.
- What is the difference in immunization, hib3 between Denmark and East Asia & Pacific (IDA & IBRD countries)?
- 55.9%, with Denmark ahead.
- How many years of comparable data are there for Denmark and East Asia & Pacific (IDA & IBRD countries)?
- 32 years are reported by both, from 1993 to 2024.
- How do Denmark and East Asia & Pacific (IDA & IBRD countries) rank globally for immunization, hib3?
- Denmark ranks 46th and East Asia & Pacific (IDA & IBRD countries) ranks 43rd of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.